Skin biopsies in the evaluation of atypical optic neuropathies

References

• Dutton J J, Burde R M, Klingele T G. Autoimmune retrobulbar optic neuritis. Am J Ophthalmol 1982; 94: 11–17
   PubMed Web of Science ®Google Scholar
• Kupersmith M J, Burde R M, Warren F A, Klingele T G, Frohman L P, Mitnick H. Autoimmune optic neuropathy: Evaluation and treatment. J Neurol Neurosurg Psychiat 1988; 51: 1381–1386
   PubMed Web of Science ®Google Scholar
• Klingele T G, Burde R M. Oligoclonal banding in autoimmune optic neuritis. J Am Med Assoc 1982; 248, 1974
   Google Scholar
• Fleet W S, Watson R T. Autoimmune optic neuritis: A potentially treatable form of visual loss. Ann Ophthalmol 1986; 18: 144–146
   PubMedGoogle Scholar
• Smith C A, Pinals R S. Optic neuritis in systemic lupus erythematosus. J Rheumatol 1982; 9: 963–966
   PubMed Web of Science ®Google Scholar
• Jabs D A, Miller N R, Newman S A, Johnson M A, Stevens M B. Optic neuropathy in systemic lupus erythematosus. Arch Ophthalmol 1986; 104: 564–568
   PubMedGoogle Scholar
• Levine S R, Crafts J W, Lesser G R, Floberg J, Welch M A. Visual symptoms associated with the presence of lupus anticoagulant. Ophthalmology 1988; 95: 686–692
   PubMedGoogle Scholar
• Colaco C B, Elkon K B. The lupus anticoagulant. A disease marker in antinuclear antibody-negative lupus that is cross reactive with auto-antibodies to double stranded DNA. Arthritis Rheumatol 1985; 28: 67–74
   PubMedGoogle Scholar
• Bradley W G, Whitty C M. Acute optic neuritis: Its clinical features and their relation to prognosis for recovery of vision. J Neurol Neurosurg Psychiat 1967; 30: 531–538
   PubMed Web of Science ®Google Scholar
• Hackett E R, Martinez R D, Larson P F, et al. Optic neuritis in systemic lupus erythematosus. Arch Neurol 1974; 31: 9–11
   PubMedGoogle Scholar
• Frohman L, Rescigno R, Holland C, Bielory L. Visual manifestations of the antiphospholipid antibody syndrome. Ophthalmology 1989; 96(suppl)105
   Google Scholar
• Downham T F. Bullous dermatoses and lupus erythematosus: Use of immunofluorescent microscopy in differential diagnosis. Dermatologic Immunology and Allergy, J Stone. CV Mosby, Princeton NY 1985; 263–272
   Google Scholar
• Tan E M, Cohen A S, Fries J F, Masi A T, McShane D J, Rothfield N F, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheumatol 1982; 25: 1271–1277
   PubMed Web of Science ®Google Scholar
• Burnham T K, Neblett T R, Fine G. The application of fluorescent antibody technique in the investigation of lupus erythematosus and various dermatoses. J Invest Dermatol 1963; 41: 451–456
   PubMedGoogle Scholar
• Halberg P, Ullman S, Jorgensen F. The lupus band test as a measure of disease activity in systemic lupus erythematosus. Arch Dermatol 1982; 118: 572–576
   PubMedGoogle Scholar
• Espinoza L R, Jara L J, Silveira L H, Martinez-Osura P, Zwolinska J B, Kneer C, Aguilar J L. Anticardiolipin antibodies in polymyalgia rheumatica-giant cell arteritis: Association with severe vascular complications. Am J Med 1991; 90: 474–478
   PubMed Web of Science ®Google Scholar
• Qamar T, Levy R A, Sammaritano L, Gharavi A E, Lockshin M D. Characteristic of high-titer IgG antiphospholipid antibody in systemic lupus erythematosus patients with and without fetal death. Arthritis Rheumatol 1990; 33: 501–504
   PubMedGoogle Scholar
• Drenkard C, Sanchez-Guerrero J, Alarcon-Segovia D. Fall in antiphospholipid antibody at the time of thromboocclusive episodes in systemic lupus erythematosus. J Rheumatol 1989; 16: 614–617
   PubMed Web of Science ®Google Scholar
• Deleze M, Orio C V, Alarcon-Segovia D. Occurrence of both hemolytic anemia and thrombocytopenia purpura (Evan's syndrome) in systemic lupus erythematosus: Relationship to antiphospholipid antibodies. J Rheumatol 1988; 15: 611–615
   PubMedGoogle Scholar
• Levine S R, Welch K M. The spectrum of neurologic disease associated with antiphospholipid antibodies: Lupus anticoagulants and anticardiolipin antibodies. Arch Neurol 1987; 44: 876–883
   PubMedGoogle Scholar
• Grob J J, Bonerandi J J. Cutaneous manifestations associated with the presence of the lupus anticoagulant. J Am Acad Dermatol 1986; 15: 211–219
   PubMedGoogle Scholar
• Gerber S L, Cantor L B. Progressive optic atrophy and the primary antiphospholipid antibody syndrome. Am J Ophthalmol 1990; 110: 443–444
   PubMedGoogle Scholar
• Jonas J, Kolble K, Volcker H E, Kalden J R. Central retinal artery occlusion in Sneddon's disease associated with antiphospholipid antibodies. Am J Ophthalmol 1986; 102: 37–40
   PubMedGoogle Scholar
• Oppenheimer S, Hoffbrand B I. Optic neuritis and myelopathy in systemic lupus erythematosus. Can J Neurol Sci 1986; 13: 129–132
   PubMedGoogle Scholar
• Digre K B, Durcan F J, Branch D W, Jacobson D M, Varner M W, Baringer J R. Amaurosis fugax associated with antiphospholipid antibodies. Ann Neurol 1989; 25: 228–232
   PubMed Web of Science ®Google Scholar
• Levine S R, Crofts J W, Lesser G R, Floberg J, Welch K MA. Visual symptoms associated with the presence of a lupus anticoagulant. Ophthalmology 1988; 95: 686–692
   PubMedGoogle Scholar
• Landi G, Calloni M V, Grazia Sabbadini M G, Mannuccio P M, Candelise L. Recurrent ischemic attacks in two young adults with lupus anticoagulant. Stroke 1983; 14: 337–379
   Google Scholar
• Kleiner R C, Najarian L V, Schatten S, Jabs D A, Patz A, Kaplan H J. Vaso-occlusive retinopathy associated with antiphospholipid antibodies (lupus anticoagulant retinopathy). Ophthalmology 1989; 96: 896–904
   PubMed Web of Science ®Google Scholar
• Pulido S S, Ward L M, Fishman G A. Antiphospholipid antibodies associated with retinal vascular disease. Retina 1987; 7: 215–218
   PubMedGoogle Scholar
• Bielory L, Shah H, Cohen A, Frohman L. Localization of phospholipid-zones in human optic nerve. Invest Ophthalmol Vis Sci 1990; 31(4)39
   Google Scholar
• Bielory L, Dong Z, Yip P, Frohman L. Anticardiolipin antibody binding to human optic nerve. Clin Res 1989; 37: 855a
   Google Scholar
• Colaco C B, Scadding G K, Lockhart S. Anti-cardiolipin antibodies in neurologic disorders: Cross-reaction with anti-single stranded DNA activity. Clin Exp Immunol 1987; 68: 313–319
   PubMedGoogle Scholar
• Grob J J, Bonerandi J J. Cutaneous manifestations associated with the presence of the lupus anticoagulant. J Am Acad Dermatol 1986; 15: 211–219
   PubMedGoogle Scholar
• Bielory L B, Cohen A, Frohman L P. Migraines, spontaneous abortions, central nervous system involvement and a positive VDRL in a 36-year-old white female. Ann Allergy 1990; 65: 447–453
   PubMedGoogle Scholar
• Lanham J G, Barrie T, Kohner E M, Hughes G R. SLE retinopathy: Evaluation by fluorescein angiography. Ann Rheum Dis 1982; 41: 473–478
   PubMed Web of Science ®Google Scholar
• Silverman M, Lubeck M J, Briney W G. Central retinal vein occlusion complicating systemic lupus erythematosus. Arthritis Rheumatol 1978; 21: 839–843
   Google Scholar
• Colaco C B, Elkon K B. The lupus anticoagulant. A disease marker in antinuclear antibody-negative lupus that is cross reactive with auto-antibodies to double stranded DNA. Arthritis Rheumatol 1985; 28: 67–74
   PubMedGoogle Scholar
• Drenkard C, Sandhez-Guerrero J, Alarcon-Segovia D. Fall in antiphospholipid antibody at time of thromboocclusive episodes in systemic lupus erythematosus. J Rheumatol 1989; 16: 614–617
   PubMed Web of Science ®Google Scholar
• Grob J J, Bonerandi J J. Cutaneous manifestations associated with the presence of the lupus anticoagulant. J Am Acad Dermatol 1986; 15: 211–219
   PubMedGoogle Scholar
• Briley D P, Coull B M, Goodnight S H. Neurological disease associated with antiphospholipid antibodies. Ann Neurol 1989; 25: 221–227
   PubMed Web of Science ®Google Scholar
• Asherson R A, Khamashta M A, Gil A, Vazquez J J, Chan O, Baquley E, Hughes G R. Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome. Am J Med 1989; 86: 391–399
   PubMed Web of Science ®Google Scholar
• Asherton R A, Mackay I R, Harris E N. Myocardial infarction in a young man with systemic lupus erythematosus, deep vein thrombosis, and antibodies to phospholipid. Br Heart J 1986; 56: 190–193
   PubMedGoogle Scholar
• Hamsten A, Norberg R, Bjorkholm M, de Fair U, Holm G. Antibodies to cardiolipin in young survivors of myocardial infarction: An association with recurrent cardiovascular events. Lancet 1986; 1: 113–116
   PubMed Web of Science ®Google Scholar
• Fields R A, Toubbeh H, Searles R P, Bankhurst A D. The prevalence of anticardiolipin antibodies in a healthy elderly population and its association with antinuclear antibodies. J Rheumatol 1989; 16: 623–625
   PubMed Web of Science ®Google Scholar